BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 28130961)

  • 1. Molecular Features in Lymphatic Metastases Reflect the Metastasis Mechanism of Lymph Nodes With Non-Small-Cell Lung Cancers.
    Guo N; Chen Y; Jing Z; Liu S; Su J; Li R; Duan X; Chen Z; Chen P; Yin R; Li S; Tang J
    Front Bioeng Biotechnol; 2022; 10():909388. PubMed ID: 35923575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-339-5p Increases Radiosensitivity of Lung Cancer Cells by Targeting Phosphatases of Regenerating Liver-1 (PRL-1).
    Wang J; Jiang M; Xia S
    Med Sci Monit; 2018 Nov; 24():8408-8416. PubMed ID: 30462625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations Between mRNA Levels of Centrosomal Protein 55 (CEP55) and Clinical Features of Patients with Lung Cancer.
    Ma XP; Zhang W; Wu BQ; Qin J
    Med Sci Monit; 2018 May; 24():3093-3097. PubMed ID: 29750778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.
    Vilmar A; Sørensen JB
    Lung Cancer; 2009 May; 64(2):131-9. PubMed ID: 18804893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing for excision repair cross-complementing 1 in patients with non-small-cell lung cancer for chemotherapy response.
    Felip E; Rosell R
    Expert Rev Mol Diagn; 2007 May; 7(3):261-8. PubMed ID: 17489733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Molecular Markers in Primary Sites and Metastatic Lymph Nodes of Lung Cancer Patients.
    Li J; Zhang W; Guo N; Yu J; Zhao Y; Li S
    Med Sci Monit; 2017 Jan; 23():513-520. PubMed ID: 28130961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of ERCC-1 in the primary tumors and metastatic lymph nodes of patients with non-small cell lung cancer adenocarcinoma.
    Zhang W; Guo N; Yu C; Wang H; Zhang Y; Xia H; Yu J; Lu J
    Tumour Biol; 2012 Dec; 33(6):2209-16. PubMed ID: 22890830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential expressions of MDR-1, RRM-1, EGFR and ERCC-1 in primary tumors and metastatic lymph nodes of NSCLC patients].
    Guo N; Li S; Zhang W; Yu C; Wang H; Zhang Y; Yu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):870-3. PubMed ID: 23948418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the expression profiles of excision repair crosscomplementation group 1, x-ray repair crosscomplementation group 1, and betaIII-tubulin between primary non-small cell lung cancer and metastatic lymph nodes and the significance in mid-term survival.
    Kang CH; Jang BG; Kim DW; Chung DH; Kim YT; Jheon S; Sung SW; Kim JH
    J Thorac Oncol; 2009 Nov; 4(11):1307-12. PubMed ID: 19745766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung.
    Udagawa H; Ishii G; Morise M; Umemura S; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Tsuboi M; Goto K; Ochiai A; Ohe Y
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1417-25. PubMed ID: 25573625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Expression of the Epithelial-Mesenchymal Transition-Related Factor Brachyury in Intrathoracic Lymphatic Spread of Non-Small Cell Lung Cancer.
    Shimamatsu S; Okamoto T; Haro A; Kitahara H; Kohno M; Morodomi Y; Tagawa T; Okano S; Oda Y; Maehara Y
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1012-1020. PubMed ID: 27600618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Plasma miRNA-30a as a Biomarker for Non-Small Cell Lung Cancer.
    Sun L; Chen Y; Su Q; Tang X; Liang Y; Che G; Luo F
    Med Sci Monit; 2016 Feb; 22():647-55. PubMed ID: 26918265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy.
    Huang W; Mao Y; Zhan Y; Huang J; Wang X; Luo P; Li LI; Mo D; Liu Q; Xu H; Huang C
    Oncol Lett; 2016 Jan; 11(1):723-730. PubMed ID: 26870274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Explore the influence factors on primary lung cancer in Fujian province Han population under the use of generalized linear model].
    He F; Xiao R; Yu T; Zhang X; Liu Z; Cai L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Aug; 36(8):896-9. PubMed ID: 26714551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature.
    Polo V; Zago G; Frega S; Canova F; Bonanno L; Favaretto A; Bonaldi L; Bertorelle R; Conte P; Pasello G
    Am J Case Rep; 2015 Nov; 16():782-9. PubMed ID: 26525068
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.